NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma
- 1 January 2011
- journal article
- research article
- Vol. 4 (2), 124-133
Abstract
Anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma (ALK+ ALCL) is an aggressive non-Hodgkin lymphoma of T/null immunophenotype that is most prevalent in children and young adults. The normal cellular counterpart of this malignancy is presumed to be the cytotoxic T lymphocyte (CTL), and this presumption is partly based on the observation that these tumour cells often express cytotoxic granules containing Granzyme B (GzB) and Perforin. Chromosomal translocations involving the gene encoding for the ALK tyrosine kinase are also characteristic of ALK+ ALCL, and the resulting fusion proteins (e. g. NPM-ALK) initiate signalling events important in ALK+ ALCL pathogenesis. These events include the elevated expression of JunB; an AP-1 family transcription factor that promotes ALK+ ALCL proliferation. In this report we demonstrate that JunB is a direct transcriptional activator of GzB and that GzB transcription is also promoted by NPM-ALK. We found that Perforin expression was not regulated by JunB, but was promoted by NPM-ALK in some cell lines and inhibited by it in others. In conclusion, our study makes the novel observation that signalling through NPM-ALK and JunB affect the expression of cytotoxic molecules in ALK+ ALCL. Moreover, these findings demonstrate the expression of GzB and Perforin in this lymphoma is not solely due its presumed CTL origin, but that oncogenic signalling is actively influencing the expression of these proteins.Keywords
This publication has 32 references indexed in Scilit:
- Anaplastic Large Cell Lymphomas: A Study of 75 Pediatric PatientsPediatric and Developmental Pathology, 2007
- c-Jun Expression and Activation are Restricted to CD30+ Lymphoproliferative DisordersThe American Journal of Surgical Pathology, 2007
- The Expression of CD30 in Anaplastic Large Cell Lymphoma Is Regulated by Nucleophosmin-Anaplastic Lymphoma Kinase–Mediated JunB Level in a Cell Type–Specific MannerCancer Research, 2006
- The Epstein-Barr Virus Protein, Latent Membrane Protein 2A, Co-opts Tyrosine Kinases Used by the T Cell ReceptorJournal of Biological Chemistry, 2005
- JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosisLaboratory Investigation, 2005
- JunB Induced by Constitutive CD30–Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase Signaling Activates the CD30 Promoter in Anaplastic Large Cell Lymphoma and Reed-Sternberg Cells of Hodgkin LymphomaCancer Research, 2005
- Recent developments in the transcriptional regulation of cytolytic effector cellsNature Reviews Immunology, 2004
- ALK+ lymphoma: clinico-pathological findings and outcome.1999
- A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomasJournal of Clinical Pathology, 1999
- CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology.1998